Renaissance Capital logo

Onconetix (Blue Water Vaccines) Priced, Nasdaq: ONCO

Preclinical biotech developing in-licensed vaccines for the flu and other infectious diseases.

Industry: Health Care

Latest Trade: $2.90 0.00 (0.0%)

First Day Return: +537.8%

Return from IPO: -99.2%

Industry: Health Care

We are a biotechnology company focused on the research and development of transformational vaccines to prevent infectious diseases worldwide. Our versatile vaccine platform has unique molecular properties that enables delivery of various antigens, which can be utilized to develop singular or multi-targeted vaccines. Our lead influenza (flu) vaccine program uses proprietary technology to identify specific epitopes, or proteins, with cross-reactive properties that enables the potential development of a universal flu vaccine. We are focused on developing novel vaccines that induce durable and long-term immunity. We believe that our pipeline and vaccine platform are synergistic for developing next generation preventive vaccines to improve both health outcomes and quality of life globally. Our pipeline includes novel vaccine candidates exclusively licensed from renowned research institutions. We seek to develop vaccines that provide long-lasting immunity to harmful viral and bacterial pathogens that cause infections in patient populations with high unmet needs. Our exclusive license agreements include patented influenza epitopes of limited variability, or ELV, identified through a proprietary computational research and discovery process, discovered by Dr. Sunetra Gupta and her team at the University of Oxford.
more less
IPO Data
IPO File Date 10/08/2021
Offer Price $9.00
Price Range $8.00 - $10.00
Offer Shares (mm) 2.2
Deal Size ($mm) $20
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 02/17/2022
Offer Price $9.00
Price Range $8.00 - $10.00
Offer Shares (mm) 2.2
Deal Size ($mm) $20
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Boustead Securities
Company Data
Headquarters Cincinnati, OH, United States
Founded 2018
Employees at IPO 9
Website www.bluewatervaccines.com

Onconetix (Blue Water Vaccines) (ONCO) Performance